Health Care & Life Sciences » Biotechnology | Vascular Biogenics Ltd.

Vascular Biogenics Ltd.

Vascular Biogenics Ltd.
Stock Exchange NASDAQ Stock Market
EPS
$0.63
Market Cap
$46.61 M
Shares Outstanding
35.85 M
Public Float
21.6 M

Profile

Address
8 HaSatat Street
Modi'in JM 7178106
Israel
Employees -
Website http://www.vblrx.com
Updated 07/08/2019
Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of first-in-class treatments for cancer. It offers different programs for cancer and inflammatory disease patients such as vascular targeting system and Lecinoxoids. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.

Financials

View All

Dror Harats
Chief Executive Officer & Director
Susan L. Kelley
Director